Wave life sciences to present at the 2022 jefferies healthcare conference

Cambridge, mass., may 25, 2022 (globe newswire) -- wave life sciences ltd. (nasdaq: wve), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that paul bolno, md, mba, president and chief executive officer, is scheduled to participate in an analyst-led fireside chat at the 2022 jefferies healthcare conference in new york city on wednesday, june 8, 2022, at 3:00 p.m. et.
WVE Ratings Summary
WVE Quant Ranking